FDA Approved: YUSIMRY — Original Application (Coherus BioSciences Inc)

View source ↗

Summary

FDA approved YUSIMRY (adalimumab-aqvh) from Coherus BioSciences in an original biologics license application, likely as a biosimilar to adalimumab.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ankylosing Spondylitis
• Crohn Disease
• Hidradenitis Suppurativa
• Juvenile Idiopathic Arthritis
• Plaque Psoriasis
• Psoriatic Arthritis
• Rheumatoid Arthritis
• Ulcerative Colitis

Drugs mentioned

• YUSIMRY (ADALIMUMAB-AQVH)

Snippet

ORIG AP for YUSIMRY (ADALIMUMAB-AQVH)